DISEASE MODIFYING PHARMACOLOGICAL APPROACH OF MULTIPLE SCLEROSIS. A FOCUS ON GLATIRAMER ACETATE

Văcăraş V. ¹, Major Z. Z. ², Buzoianu Anca Dana ^2
1 „Iuliu Haţieganu” University of Medicine and Pharmacy, Neurology Department, Cluj-Napoca
² „Iuliu Haţieganu” University of Medicine and Pharmacy, Pharmacology Department, Cluj-Napoca

Abstract

Multiple sclerosis is a neurological disease with diverse treatment options, but one of the main tools of maintaining a relatively acceptable life quality is the pharmacological approach through disease modifying therapies. The objective of this paper is to give a brief presentation of the main feasible drug options, a higher attention being offered to glatiramer acetate.